BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

385 related articles for article (PubMed ID: 25824073)

  • 1. Non-alcoholic fatty liver disease: when to intervene and with what.
    Than NN; Newsome PN
    Clin Med (Lond); 2015 Apr; 15(2):186-90. PubMed ID: 25824073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-alcoholic fatty liver disease in obese adults: clinical aspects and current management strategies.
    Pallayova M; Taheri S
    Clin Obes; 2014 Oct; 4(5):243-53. PubMed ID: 25825857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pediatric non-alcoholic fatty liver disease: Recent solutions, unresolved issues, and future research directions.
    Clemente MG; Mandato C; Poeta M; Vajro P
    World J Gastroenterol; 2016 Sep; 22(36):8078-93. PubMed ID: 27688650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonalcoholic Fatty Liver Disease and Diabetes: Part II: Treatment.
    Kim KS; Lee BW; Kim YJ; Lee DH; Cha BS; Park CY
    Diabetes Metab J; 2019 Apr; 43(2):127-143. PubMed ID: 30993937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of non-alcoholic fatty liver disease.
    Dyson J; Day C
    Dig Dis; 2014; 32(5):597-604. PubMed ID: 25034293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is Nonalcoholic Fatty Liver Disease Indeed the Hepatic Manifestation of Metabolic Syndrome?
    Katsiki N; Perez-Martinez P; Anagnostis P; Mikhailidis DP; Karagiannis A
    Curr Vasc Pharmacol; 2018; 16(3):219-227. PubMed ID: 28669328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Critical Approach of Guideline Therapeutic Recommendations for NAFLD.
    Djordjevic DB; Zdravkovic M; Nagorni A; Manolis A; Tsioufis C; Lovic D
    Curr Vasc Pharmacol; 2018; 16(3):228-238. PubMed ID: 28676026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonalcoholic fatty liver disease: current concepts, epidemiology and management strategies.
    Tomic D; Kemp WW; Roberts SK
    Eur J Gastroenterol Hepatol; 2018 Oct; 30(10):1103-1115. PubMed ID: 30113367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Managing non-alcoholic fatty liver disease.
    Ngu JH; Goh GB; Poh Z; Soetikno R
    Singapore Med J; 2016 Jul; 57(7):368-71. PubMed ID: 27439352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The diagnosis and treatment of non-alcoholic fatty liver disease.
    Altinbas A; Sowa JP; Hasenberg T; Canbay A
    Minerva Gastroenterol Dietol; 2015 Sep; 61(3):159-69. PubMed ID: 26080905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evolution of NAFLD and Its Management.
    Mundi MS; Velapati S; Patel J; Kellogg TA; Abu Dayyeh BK; Hurt RT
    Nutr Clin Pract; 2020 Feb; 35(1):72-84. PubMed ID: 31840865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modern approach to the clinical management of non-alcoholic fatty liver disease.
    Del Ben M; Polimeni L; Baratta F; Pastori D; Loffredo L; Angelico F
    World J Gastroenterol; 2014 Jul; 20(26):8341-50. PubMed ID: 25024593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Weight Loss, Diet, Exercise, and Bariatric Surgery on Nonalcoholic Fatty Liver Disease.
    Hannah WN; Harrison SA
    Clin Liver Dis; 2016 May; 20(2):339-50. PubMed ID: 27063273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-alcoholic fatty liver disease.
    Maurice J; Manousou P
    Clin Med (Lond); 2018 Jun; 18(3):245-250. PubMed ID: 29858436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and Predictors of Non-Alcoholic Fatty Liver Disease in Morbidly Obese South Indian Patients Undergoing Bariatric Surgery.
    Praveenraj P; Gomes RM; Kumar S; Karthikeyan P; Shankar A; Parthasarathi R; Senthilnathan P; Rajapandian S; Palanivelu C
    Obes Surg; 2015 Nov; 25(11):2078-87. PubMed ID: 25835982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Occurrence and clinical management of nonalcoholic fatty liver disease in obesity patients: a literature review.
    Cui H; Zhang X
    J Pediatr Endocrinol Metab; 2020 May; 33(5):579-584. PubMed ID: 32187014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Non-alcoholic fatty liver disease (NAFLD)].
    Rau M; Weiss J; Geier A
    Dtsch Med Wochenschr; 2015 Jul; 140(14):1051-5. PubMed ID: 26182253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A concise review of non-alcoholic fatty liver disease.
    Than NN; Newsome PN
    Atherosclerosis; 2015 Mar; 239(1):192-202. PubMed ID: 25617860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Consensus document. Management of non-alcoholic fatty liver disease (NAFLD). Clinical practice guideline.
    Aller R; Fernández-Rodríguez C; Lo Iacono O; Bañares R; Abad J; Carrión JA; García-Monzón C; Caballería J; Berenguer M; Rodríguez-Perálvarez M; Miranda JL; Vilar-Gómez E; Crespo J; García-Cortés M; Reig M; Navarro JM; Gallego R; Genescà J; Arias-Loste MT; Pareja MJ; Albillos A; Muntané J; Jorquera F; Solà E; Hernández-Guerra M; Rojo MÁ; Salmerón J; Caballería L; Diago M; Molina E; Bataller R; Romero-Gómez M
    Gastroenterol Hepatol; 2018 May; 41(5):328-349. PubMed ID: 29631866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current management of non-alcoholic fatty liver disease.
    Lisboa QC; Costa SM; Couto CA
    Rev Assoc Med Bras (1992); 2016 Dec; 62(9):872-878. PubMed ID: 28001263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.